H25.2
Age-related cataract, morgagnian type
Clinical Classification Guidelines
Inclusion Terms
- Age-related hypermature cataract
Medical Intelligence & Overview
Age-related cataract, Morgagnian type (ICD-10 code H25.2), is a specific form of cataract that typically develops in older adults. This type of cataract is characterized by a hypermature stage, where the lens becomes completely cloudy and the internal structures may liquefy. Named after the Morgagnian cataract, it represents an advanced phase of age-related lens clouding, primarily affecting vision and quality of life. Recognizing this condition early can help in managing its progression effectively.
Causes & Symptoms
Clinical Causes: Aging process leading to protein changes in the lens over time Genetic predisposition to early or severe lens clouding Diabetes mellitus, contributing to faster lens opacification Trauma or injury to the eye that accelerates cataract formation Extended exposure to ultraviolet (UV) light damaging lens proteins Certain medications, such as corticosteroids, which can increase the risk Environmental factors like smoking or poor nutrition
Key Symptoms: Gradual decline in visual clarity Increased sensitivity to glare and bright lights Difficulty seeing at night or in dim lighting Blurred or cloudy vision that worsens over time Fading or yellowing of colors Possible perception of a halo effect around lights
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Morgagnian cataract involves a comprehensive eye examination by an ophthalmologist, including:
Treatment Protocols: Treatment options for age-related Morgagnian cataract primarily involve surgical intervention, with the goal of restoring vision. The main procedures include:
Clinical Advice & FAQs
Billing Guidance
Is H25.2 a billable ICD-10 code?
Yes, H25.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H25.2?
Clinical documentation must specify the nature of Age-related cataract, morgagnian type and any associated comorbidities for accurate reporting.
Cite this Clinical Reference